
Avid Bioservices Inc
NASDAQ:CDMO

Intrinsic Value
The intrinsic value of one
CDMO
stock under the Base Case scenario is
8.43
USD.
Compared to the current market price of 12.49 USD,
Avid Bioservices Inc
is
Overvalued by 32%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Avid Bioservices Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Avid Bioservices Inc
Balance Sheet Decomposition
Avid Bioservices Inc
Current Assets | 96.5m |
Cash & Short-Term Investments | 33.4m |
Receivables | 30.2m |
Other Current Assets | 32.9m |
Non-Current Assets | 227m |
PP&E | 222.6m |
Other Non-Current Assets | 4.4m |
Free Cash Flow Analysis
Avid Bioservices Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Avid Bioservices Inc
Revenue
|
150.4m
USD
|
Cost of Revenue
|
-138.9m
USD
|
Gross Profit
|
11.6m
USD
|
Operating Expenses
|
-33.8m
USD
|
Operating Income
|
-22.3m
USD
|
Other Expenses
|
-129.8m
USD
|
Net Income
|
-152.1m
USD
|
CDMO Profitability Score
Profitability Due Diligence
Avid Bioservices Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Score
Avid Bioservices Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.
CDMO Solvency Score
Solvency Due Diligence
Avid Bioservices Inc's solvency score is 19/100. The higher the solvency score, the more solvent the company is.

Score
Avid Bioservices Inc's solvency score is 19/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CDMO Price Targets Summary
Avid Bioservices Inc
According to Wall Street analysts, the average 1-year price target for
CDMO
is 12.75 USD
with a low forecast of 12.63 USD and a high forecast of 13.13 USD.
Dividends
Current shareholder yield for CDMO is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CDMO
stock under the Base Case scenario is
8.43
USD.
Compared to the current market price of 12.49 USD,
Avid Bioservices Inc
is
Overvalued by 32%.